Inogen (INGN) remains unprofitable, with losses widening at a 31.9% annual rate over the past five years. Forecasts show its net profit margin is expected to stay negative for at least three more ...

Inogen Inc (NASDAQ:INGN) achieved its 6th consecutive quarter of mid-single-digit growth, with approximately $92 million in revenue. The company reported a 19% increase in overall unit volumes, driven ...

Inogen Inc (NASDAQ:INGN) released its Q2 2025 financial results on August 7, 2025, revealing continued revenue growth despite mixed performance across business segments. The company’s stock closed at ...

Inogen Inc. (INGN) reported its first-quarter 2025 earnings, showcasing a notable improvement in financial performance compared to prior periods. The company posted a narrower-than-expected loss per ...

Operator: Welcome to Inogen’s Second Quarter 2025 Earnings Conference Call. [Operator Instructions] As a reminder, this conference is being recorded today, August 7, 2025. I would now like to turn the ...

GOLETA, Calif.--(BUSINESS WIRE)-- Inogen, Inc. (INGN) (Nasdaq: INGN), a medical technology company offering innovative respiratory products for use in the homecare setting, today announced preliminary ...